Replies to post #3705 on Repros Therapeutics Inc (RPRX)

[docbanker]

I'm glad. I feel like if this level of not only diligence but in my mind persistent doubt and "nitpicking" were done on a number of other names in the sector, I suspect the holdings of many of these posters would be dramatically lower.

For MNTA, Dew and whoever else cant put together a cognizant argument for a drug who already received a "not approvable" and they cheer when there is short covering from $8-10. Now its 8s again. For RPRX, we beat the same dead horse over and over and no one is satisfied. P values of 10 to the mius 7 or whatever are challenged routinely. The hurdle is different.

[quantumdot]

Clark - you are right that it is more subtle with differing tissue effects. If you want accurate answers always start with dewophile's posts.

re proellex
see #msg-22932711

re androxal
see #msg-24835112

these are just a quick start. he likely has more detailed explanations in some other posts. i suggest you search and read all his posts.

re the vasomax history - I dont have the time/interest to dig too deep but here is some interesting musings re intent from one of the court cases...

http://www.bloomt-hal.com/chapter3/3_09_2.htm